GlassScriptPhysician profile
John Paul Hall
NPI 1609816719
$2,725.02
in general payments reported to CMS, 2019-2025
38 companies · $591 in 2025
The $591 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.49 · 2020: $12.75 · 2021: $66.44 · 2022: $762 · 2023: $673 · 2024: $608 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $338.23 | 2019-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $292.02 | 2022-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $241.42 | 2023-2025 | |
| Urogen Pharma, INC. | $217.97 | 2022-2025 | Jelmyto |
| Amgen INC. | $136.78 | 2022-2024 | Prolia, Xgeva |
| Rochester Medical Corporation | $134.97 | 2022 | |
| Astellas Pharma US INC | $112.85 | 2022-2025 | Myrbetriq, Xtandi, Veozah |
| Teleflex LLC | $99.34 | 2022-2023 | Urolift |
| Sumitomo Pharma America, INC. | $91.17 | 2023-2025 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $77.38 | 2025 | |
| Abbvie INC. | $69.95 | 2022-2024 | |
| Myriad Genetic Laboratories, INC. | $65.57 | 2021-2025 | Prolaris |
| Tolmar, INC. | $59.23 | 2023-2025 | Eligard, Jatenzo |
| Ferring Pharmaceuticals INC. | $58.00 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $48.07 | 2021-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $46.32 | 2022 | |
| Endo USA, INC. | $45.22 | 2024-2025 | Xiaflex |
| Verity Pharmaceuticals INC. | $44.14 | 2024-2025 | Trelstar |
| Calyxo, INC. | $42.43 | 2024 | Cvac Aspiration System |
| Accord Healthcare, INC. | $41.59 | 2022-2025 | |
| 180 Medical, INC. | $41.45 | 2022-2024 | Gentlecath |
| Merck Sharp & Dohme LLC | $39.44 | 2025 | Lynparza, Keytruda Qlex, Keytruda |
| C. R. Bard, INC. & Subsidiaries | $36.80 | 2023 | Bard Urinary Drainage Bag |
| Axonics, INC. | $36.60 | 2022-2024 | Axonics |
| Myovant Sciences INC. | $33.66 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $32.10 | 2024-2025 | |
| Intuitive Surgical, INC. | $28.00 | 2024 | |
| Genzyme Corporation | $27.63 | 2022 | |
| Edap Technomed INC | $27.00 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $25.16 | 2024 | Exparel |
| Cook Medical LLC | $23.51 | 2025 | Cook |
| Procept Biorobotics Corporation | $18.34 | 2025 | |
| Halozyme INC | $18.05 | 2023 | |
| Urovant Sciences INC | $17.43 | 2022 | |
| Olympus America INC. | $16.67 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $14.77 | 2024 | Goby |
| Telix Pharmaceuticals | $14.03 | 2024 | Illuccix |
| Cumberland Pharmaceuticals, INC. | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.